Fossaoprin Spg4
Product Images NDC 70529-018

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Fossaoprin Spg4 (NDC 70529-018). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by It3 Medical Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula Lidocaine Hydrochloride (Lidocaine Formula 2)

Chemical structure of the active ingredient in Fossaoprin SPG4, showing its molecular formula with aromatic rings, methyl groups, and components including hydrochloride and water molecules.*

FDA Label Image

Structural Formula Bupivacaine Hydrochloride (Marcaine 01)

Chemical structure of the active ingredient in Fossaoprin SPG4, showing a piperidine ring connected to an amide group and a substituted benzene ring with methyl groups, along with hydrochloride and hydrate components.*

FDA Label Image

Structural Formula Epinephrine (Marcaine02)

Chemical structure diagram of the active ingredient in Fossaoprin SPG4, showing a benzene ring with three hydroxyl groups and a side chain including a CH2 group attached to NH and CH3 groups.*

FDA Label Image

Fossaoprin Spg4 Kit (Fossaoprin Spg4 Kit Label)

Label for Fossaoprin SPG4 Injection System by IT3 Medical LLC with NDC 70529-018. The label lists components including 5mL 4% Lidocaine HCl, 50mL 0.5% Marcaine, 3cc syringe with needle, Vacutainer hose, gauze sponge, and alcohol prep pads. It includes storage instructions, caution symbols, lot number 111617, and expiration date 8-1-18.*

FDA Label Image

Components Label (Fossaoprin Spg4 Component Label)

This image features multiple drug packaging labels including a 5 mL single-dose vial of 4% Lidocaine HCl Injection, USP (200 mg/5 mL) labeled for topical use and retrobulbar injection by Hospira, Inc.; several 50 mL multiple-dose vials of Marcaine 0.5% (bupivacaine HCl Injection, USP), 250 mg/50 mL, for nerve block and general use by Hospira, Inc.; and a McKesson Alcohol Prep Pad saturated with 70% isopropyl alcohol, sized 1.2 x 2.6 inches.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.